Dr. Harding is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Pathology, Wolstein 6522
2103 Cornell Rd
Cleveland, OH 44106Phone+1 216-368-3611
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1985 - 1990
- Washington University in St. Louis School of MedicineClass of 1985
- Harvard UniversityA.B., Biology, Magna cum laude, 1975 - 1979
Certifications & Licensure
- OH State Medical License 1993 - 2018
Awards, Honors, & Recognition
- Fellow American Association for the Advancement of Science, 2012
- Scholar Pfizer, 1991
- Junior Faculty Research Award American Cancer Society, 1991
- Join now to see all
Publications & Presentations
PubMed
- 2531 citationsB lymphocytes secrete antigen-presenting vesicles.Graça Raposo, Hans W. Nijman, Willem Stoorvogel, R Liejendekker, Clifford V. Harding
The Journal of Experimental Medicine. 1996-03-01 - 1208 citationsReceptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytesClifford V. Harding, John E. Heuser, Philip D. Stahl
The Journal of Cell Biology. 1983-08-01 - 171 citationsMycobacterium tuberculosis LprA Is a Lipoprotein Agonist of TLR2 That Regulates Innate Immunity and APC FunctionNicole D. Pecora, Adam J. Gehring, David H. Canaday, W. Henry Boom, Clifford V. Harding
Journal of Immunology. 2006-07-01
Journal Articles
- Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodesMudd, J.C., Murphy, P., Manion, M., Debernardo, R., Hardacre, J., Ammori, J., Hardy, G.A., Harding, C.V., Mahabaleshwar, G.H., Jain, M.K., Jacobson, J.M., Brooks, A.D...., Blood, 1/1/2013
- Interferon-alpha is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markersHardy, G.A.D., Sieg, S., Rodriguez, B., Anthony, D., Asaad, R., Jiang, W., Mudd, J., Schacker, T., Funderburg, N., Pilch, H., Rabin, R.L., Lederman, M.M. and Harding, ..., PLOS One, 1/1/2013
- Type I interferon drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processingSimmons, D.P., Wearsch, P.A., Canaday, D.H., Meyerson, H.J., Liu, Y.C., Wang, Y., Boom, W.H. and Harding, C.V., J. Immunol., 1/1/2012
- Join now to see all
Press Mentions
- Citywide Collaboration Awarded $46 Million Grant to Improve Regional HealthJune 26th, 2018
Grant Support
- Immunology Training Program - PredoctoralNational Institute Of Allergy And Infectious Diseases2010–2012
- M. Tuberculosis Lipoprotein-Tlr2 InteractionsNational Institute Of Allergy And Infectious Diseases2007–2011
- Medical Scientist Training ProgramNational Institute Of General Medical Sciences2001–2011
- Bacterial And Liposomal Antigen ProcessingNational Institute Of Allergy And Infectious Diseases1994–2011
- Class II MHC Transport And FunctionNational Institute Of Allergy And Infectious Diseases1994–2010
- CPG DNA Adjuvants And Vaccines For Encapsulated BacteriaNational Institute Of Allergy And Infectious Diseases2000–2004
- Allergy, Immunology &Transplantation Research CommitteeNational Institute Of Allergy And Infectious Diseases1999–2000
- Immunomodulatory Effects Of CPG DNANational Institute Of Allergy And Infectious Diseases1999
- Proteosomes And Tumor ImmunityNational Cancer Institute1996–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: